Epiglottitis is a rare but life-threatening condition that can be caused by bacteria, viruses, or other infections. Epiglottitis is an inflammation of the epiglottis and the tissues that surround it. The epiglottis is a flap of tissue at the back of the throat that helps to keep food from entering into the lungs when swallowing. Epiglottitis can cause breathing difficulties and may require hospitalization for treatment with antibiotics or surgery to remove infected tissue. The global epiglottitis drug market was valued at USD 1,890 million in 2018 and is expected to reach USD 2,907 million by 2030, growing at a CAGR of 7% during 2019-2030. Targeted Antibiotic: The targeted antibiotic segment accounted for over 50% share in 2018 owing to its high efficacy against bacterial infection which causes epiglottitis. However, this segment will witness decline in its market share due to increasing incidence rates of viral infections which are not responsive to these drugs as well as emergence of resistance among bacteria strains against these drugs. Broaspectrum Antibiotic: The broaspectrum antibiotic segment accounted for over 30% share in 2018 owing to its broad spectrum activity against both bacterial and viral infections which cause epiglotits disease thereby reducing chances of recurrence after treatment with these drugs Steroid Medication: The steroid medication segment accounted for over 10% share in 2018 owing to their ability to reduce inflammation associated with this condition thereby reducing chances of recurrence after treatment with these drugs Epiglotits Drug Market By Application Hospitals Pharmacies: Hospitals pharmacies account for over 40% share in 2018 due primarily due their high volume sales Online Pharmacies: Online pharmacies account for over 25% share in 2018 due primarily due their low cost per unit sold Retail Pharmacies: Retail pharmacies account for less than 10% shareshare. Epiglottitis is a rare disease that affects the epiglottis, a flap of tissue that covers the entrance to the larynx. Epiglottitis is caused by bacteria or viruses and can be life-threatening if not treated quickly. Symptoms include fever, sore throat, difficulty swallowing, drooling and breathing difficulties.
Industry Growth Insights published a new data on “Epiglottitis Drug Market”. The research report is titled “Epiglottitis Drug Market research by Types (Targeted Antibiotic, Broad-spectrum Antibiotic, Steroid Medication, Epiglottitis Dru), By Applications (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Players/Companies Abbott, Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Sanofi, Teva, GlaxoSmithKline, Roche, Epiglottitis Dru”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Epiglottitis Drug Market Research Report
By Type
Targeted Antibiotic, Broad-spectrum Antibiotic, Steroid Medication, Epiglottitis Dru
By Application
Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Abbott, Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Sanofi, Teva, GlaxoSmithKline, Roche, Epiglottitis Dru
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Epiglottitis Drug Market Report Segments:
The global Epiglottitis Drug market is segmented on the basis of:
Types
Targeted Antibiotic, Broad-spectrum Antibiotic, Steroid Medication, Epiglottitis Dru
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Merck
- AstraZeneca
- Boehringer Ingelheim
- Pfizer
- Sanofi
- Teva
- GlaxoSmithKline
- Roche
- Epiglottitis Dru
Highlights of The Epiglottitis Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Targeted Antibiotic
- Broad-spectrum Antibiotic
- Steroid Medication
- Epiglottitis Dru
- By Application:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epiglottitis Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Epiglottitis is a serious infection of the epiglottis, the flap of cartilage that covers the entrance to the windpipe. The infection can cause severe breathing problems and even death. Epiglottitis is most commonly caused by a virus, but it can also be caused by bacteria or fungus. Treatment typically involves antibiotics and intensive care therapy.
Some of the major players in the epiglottitis drug market are Abbott, Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Sanofi, Teva, GlaxoSmithKline, Roche, Epiglottitis Dru.
The epiglottitis drug market is expected to grow at a compound annual growth rate of 7%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Epiglottitis Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Epiglottitis Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Epiglottitis Drug Market - Supply Chain
4.5. Global Epiglottitis Drug Market Forecast
4.5.1. Epiglottitis Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Epiglottitis Drug Market Size (000 Units) and Y-o-Y Growth
4.5.3. Epiglottitis Drug Market Absolute $ Opportunity
5. Global Epiglottitis Drug Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Epiglottitis Drug Market Size and Volume Forecast by Type
5.3.1. Targeted Antibiotic
5.3.2. Broad-spectrum Antibiotic
5.3.3. Steroid Medication
5.3.4. Epiglottitis Dru
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Epiglottitis Drug Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Epiglottitis Drug Market Size and Volume Forecast by Application
6.3.1. Hospitals Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Epiglottitis Drug Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Epiglottitis Drug Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Epiglottitis Drug Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Epiglottitis Drug Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Epiglottitis Drug Demand Share Forecast, 2019-2026
9. North America Epiglottitis Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Epiglottitis Drug Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Epiglottitis Drug Market Size and Volume Forecast by Application
9.4.1. Hospitals Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Epiglottitis Drug Market Size and Volume Forecast by Type
9.7.1. Targeted Antibiotic
9.7.2. Broad-spectrum Antibiotic
9.7.3. Steroid Medication
9.7.4. Epiglottitis Dru
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Epiglottitis Drug Demand Share Forecast, 2019-2026
10. Latin America Epiglottitis Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Epiglottitis Drug Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Epiglottitis Drug Market Size and Volume Forecast by Application
10.4.1. Hospitals Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Epiglottitis Drug Market Size and Volume Forecast by Type
10.7.1. Targeted Antibiotic
10.7.2. Broad-spectrum Antibiotic
10.7.3. Steroid Medication
10.7.4. Epiglottitis Dru
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Epiglottitis Drug Demand Share Forecast, 2019-2026
11. Europe Epiglottitis Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Epiglottitis Drug Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Epiglottitis Drug Market Size and Volume Forecast by Application
11.4.1. Hospitals Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Epiglottitis Drug Market Size and Volume Forecast by Type
11.7.1. Targeted Antibiotic
11.7.2. Broad-spectrum Antibiotic
11.7.3. Steroid Medication
11.7.4. Epiglottitis Dru
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Epiglottitis Drug Demand Share, 2019-2026
12. Asia Pacific Epiglottitis Drug Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Epiglottitis Drug Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Epiglottitis Drug Market Size and Volume Forecast by Application
12.4.1. Hospitals Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Epiglottitis Drug Market Size and Volume Forecast by Type
12.7.1. Targeted Antibiotic
12.7.2. Broad-spectrum Antibiotic
12.7.3. Steroid Medication
12.7.4. Epiglottitis Dru
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Epiglottitis Drug Demand Share, 2019-2026
13. Middle East & Africa Epiglottitis Drug Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Epiglottitis Drug Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Epiglottitis Drug Market Size and Volume Forecast by Application
13.4.1. Hospitals Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Epiglottitis Drug Market Size and Volume Forecast by Type
13.7.1. Targeted Antibiotic
13.7.2. Broad-spectrum Antibiotic
13.7.3. Steroid Medication
13.7.4. Epiglottitis Dru
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Epiglottitis Drug Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Epiglottitis Drug Market: Market Share Analysis
14.2. Epiglottitis Drug Distributors and Customers
14.3. Epiglottitis Drug Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AstraZeneca
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boehringer Ingelheim
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pfizer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sanofi
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GlaxoSmithKline
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Roche
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Epiglottitis Dru
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook